857
Views
10
CrossRef citations to date
0
Altmetric
Perspectives

Reducing Creativity With Psychostimulants May Debilitate Mental Health and Well-Being

REFERENCES

  • Advokat, C. (2010). What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD). Neuroscience & Biobehavioral Reviews, 34, 1256–1266. doi:10.1016/j.neubiorev.2010.03.006
  • Amabile, T. M. (1983). The social psychology of creativity: A componential conceptualization. Journal of Personality and Social Psychology, 45, 357–376. doi:10.1037/0022-3514.45.2.357
  • Babcock, Q., & Byrne, T. (2000). Student perceptions of methylphenidate abuse at a public liberal arts college. Journal of American College Health, 49, 143–145. doi:10.1080/07448480009596296
  • Beauchamp, T. L., & Childress, J. F. (2001). Principles of biomedical ethics (pp. 165–224). New York, NY: Oxford University Press.
  • Beauchamp, T. L., & Childress, J. F. (2009). Principles of biomedical ethics ( pp. 197–239). New York, NY: Oxford University Press.
  • Bell, S., Lucke, J. C., & Hall, W. (2012). Lessons for enhancement from the history of cocaine and amphetamine use. American Journal of Bioethics: Neuroscience, 3, 24–29. doi:10.1080/21507740.2012.663056
  • Bergson, H. (1919). Creativity evolution. London, England: Macmillan.
  • Cameron, D. E. (1965). Discovery in medicine. Acta Psychiatrica Scandinavica, 41, 462–471. doi:10.1111/j.1600-0447.1965.tb05005.x
  • Carr, A. (2004). Giftedness, creativity and wisdom. In A. Carr (Eds.), Positive psychology: The science of happiness and human strengths (pp. 144–180). New York, NY: Brunner-Routledge.
  • Cassandro, V. J., & Simonton, D. K. (2003). Creativity and genius. In C. L. M. Keyes & J. Haidt (Eds.), Flourishing: Positive psychology and the life well-lived (pp. 163–183). Washington, DC: American Psychological Association. doi:10.1037/10594-007
  • Conee, E. (1982). Instrumental value without intrinsic value? Philosophia, 11, 345–359. doi:10.1007/bf02380844
  • Csikszentmihalyi, M. (1988). Motivation and creativity: Toward a synthesis of structural and energistic approaches to cognition. New Ideas in Psychology, 6, 159–176. doi:10.1016/0732-118x(88)90001-3
  • Csikszentmihalyi, M. (1996). Creativity: Flow and the psychology of discovery and invention. New York, NY: Harper Collins.
  • Csikszentmihalyi, M. (2000). Happiness, flow and economic equality. American Psychologist, 55, 1163–1164. Retrieved from http://psycnet.apa.org/psycinfo/2000-02781-022
  • Davies, G. A. (1998). Creativity is forever. Dubuque, IA: Kendall Hunt.
  • Deák, G. O. (2004). The development of cognitive flexibility and language abilities. Advances in Child Development and Behavior, 31, 271–327. Retrieved from doi:10.1016/S0065-2407(03)31007-9
  • Degenhardt, L., Bucello, C., Calabria, B., Nelson, P., Roberts, A., Hall, W., … Wiessing, L. (2011). What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews. Drug and Alcohol Dependence, 117, 85–101. doi:10.1016/j.drugalcdep.2010.11.032
  • Draper, H., & Sorell, T. (2002). Patients’ responsibilities in medical ethics. Bioethics, 16, 335–352. doi:10.1111/1467-8519.00292
  • Eysenck, H. J. (1995). Genius: The natural history of creativity. Cambridge, UK: Cambridge University Press.
  • Farah, M., Caroline, H., Sankoorikal, G., Smith, M. E., & Chatterjee, A. (2009). When we can enhance cognition with Adderall, do we sacrifice creativity? Psychopharmacology, 202, 541–547. doi:10.1007/s00213-008-1369-3
  • Flaherty, A. W. (2005). Frontotemporal and dopaminergic control of idea generation and creative drive. The Journal of Comparative Neurology, 493, 147–153. doi:10.1002/cne.20768
  • Franke, A. G., Bonertz, C., Christmann, M., Huss, M., Fellgiebel, A., Hildt, E., & Lieb, K. (2011). Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry, 44, 60–66. doi:10.1055/s-0030-1268417
  • Ganesalingam, K., Yeates, K. O., Taylor, H. G., Walz, N. C., Stancin, T., & Wade, S. (2011). Executive functions and social competence in young children 6 months following traumatic brain injury. Neuropsychology, 25, 466–476. doi:10.1037/a0022768
  • Gibson, C., Folley, B. S., & Park, S. (2009). Enhanced divergent thinking and creativity in musicians: A behavioral and near-infrared spectroscopy study. Brain and Cognition, 69, 162–169. doi:10.1016/j.bandc.2008.07.009
  • Glannon, W. (2008). Psychopharmacological enhancement. Neuroethics, 1, 45–54. doi:10.1007/s12152-008-9005-9
  • Glannon, W. (2011). Brain, body, and mind: Neuroethics with a human face. Oxford, UK: Oxford University Press.
  • Greely, H., Sahakian, B., Harris, J., Kessler, R. C., Gazzaniga, M., Campbell, P., & Farah, M. J. (2008). Towards responsible use of cognitive-enhancing drugs by the healthy. Nature, 456, 702–705. doi:10.1038/456702a
  • Guilford, J. P. (1957). Creative abilities in the arts. Psychological Review, 64, 110–118. doi:10.1037/h0048280
  • Hennessey, B. A., & Amabile, T. M. (2010). Creativity. Annual Review of Psychology, 61, 569–598. doi:10.1146/annurev.psych.093008.100416
  • Iversen, L., Iversen, S., Bloom, F. E., & Roth, R. H. (2009). Introduction to neuropsychopharmacology. Oxford, UK: Oxford University Press.
  • Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2011). Monitoring the future: National results on adolescent drug use: Overview of key findings, 2010. Ann Arbor: Institute for Social Research, The University of Michigan. Retrieved from http://monitoringthefuture.org/pubs/monographs/mtf-overview2010.pdf
  • Kant, I. (1797). Metaphysics of morals. Cambridge, UK: Cambridge University Press.
  • Kasof, J. (1997). Creativity and breadth of attention. Creativity Research Journal, 10, 303–315. doi:10.1207/s15326934crj1004_2
  • Kaufman, J. C., & Sternburg, R. J. (2006). Introduction. In J. C. Kaufman & R. J. Sternburg (Eds.), The international handbook of creativity ( pp. 1–6). Cambridge, UK: Cambridge University Press.
  • Kim, K. H. (2011). The American Psychological Association 2009 Division 10 debate: Are the Torrance Tests of Creative Thinking still relevant in the 21st century? Psychology of Aesthetics, Creativity, and the Arts, 5, 302–308. doi:10.1037/a0021917
  • Krueger, J., & Killham, E. (2006). Who’s driving innovation at your company? Gallup Management Journal. Retrieved from http://gmj.gallup.com/content/24472/whos-driving-innovation-your-company.aspx?version=print
  • Lucke, J. C., Bell, S., Partridge, B., & Hall, W. D. (2011). Deflating the neuroenhancement bubble. American Journal of Bioethics: Neuroscience, 2, 38–43. doi:10.1080/21507740.2011.611122
  • Martindale, C., & Dailey, A. (1996). Creativity, primary process cognition and personality. Personality and Individual Differences, 20, 409–414. doi:10.1016/0191-8869(95)00202-2
  • Martins, M. W. (2007). Creativity: Ethics and excellence in science. Lanham, MD: Lexington.
  • Maslow, A. H. (1954). Motivation and personality. Oxford, UK: Harpers.
  • Maslow, A. H. (1970). Motivation and personality (3rd ed.). London, England: Harper Collins.
  • Mednick, S. (1962). The associative basis of the creative process. Psychological Review, 69, 220–232. doi:10.1037/h0048850
  • Mednick, S. A., & Mednick, M. T. (1967). Examiner’s manual: Remote Associates Test. Boston, MA: Houghton Mifflin.
  • Mehta, M. A., Sahakian, B. J., McKenna, P. J., & Robbins, T. W. (1999). Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson’s disease. Psychopharmacology, 146, 162–174. doi:10.1007/s002130051102
  • Mohamed, A. D. (2012a). The effects of modafinil on cold cognition, creativity and motivation in healthy subjects. Abstracts from the 28th CINP World Congress of Neuropsychopharmacology. The International Journal of Neuropsychopharmacology, 15, 239–240. doi:10.1017/S1461145712000508
  • Mohamed, A. D. (2012b). Modafinil has the potential for addiction. American Journal of Bioethics: Neuroscience, 3, 36–38. doi:10.1080/21507740.2012.666322
  • Mohamed, A. D., & Sahakian, B. J. (2012). The ethics of elective psychopharmacology. The International Journal of Neuropsychopharmacology, 15, 559–571. doi:10.1017/S146114571100037X.1-13
  • Mumford, M. D., Waples, E. P., Antes, A. L., Brown, R. P., Connelly, S., Murphy, S. T., & Devenport, L. D. (2010). Creativity and ethics: The relationship of creative and ethical problem-solving. Creativity Research Journal, 22, 74–89. doi:10.1080/10400410903579619
  • National Institute on Drug Abuse. (2012). Drug facts: High school and youth trends. Retrieved from http://www.drugabuse.gov/publications/drugfacts/high-school-youth-trends
  • Oldham, G. R., & Baer, M. (2012). Creativity and the work context. In D. M. Michael (Ed.), Handbook of organizational creativity (pp. 387–420). San Diego, CA: Academic.
  • Parens, E. (2007). Enhancing human traits: Ethical and social implications. Washington, DC: Georgetown University Press.
  • Parfit, D. (1984). Reasons and persons. New York, NY: Oxford University Press.
  • Partridge, B. J., Bell, S. K., Lucke, J. C., Yeates, S., & Hall, W. D. (2011). Smart drugs ‘as common as coffee’: Media hype about neuroenhancement. Plos One, 6(11), e28416. doi:10.1371/journal.pone.0028416
  • Peterson, C., & Park, N. (2006). Character strengths in organizations. Journal of Organizational Behavior, 27, 1149–1154. doi:10.1002/job.398
  • Peterson, C., & Saligman, M. E. P. (2004). Character strengths and virtues: A handbook and classification. Washington, DC: American Psychological Association.
  • Racine, E. (2010). Pragmatic neuroethics: Improving treatment and understanding of the mind-brain. Cambridge, MA: MIT Press.
  • Randall, D. C., Fleck, N. L., Shneerson, J. M., & File, S. E. (2004). The cognitive-enhancing properties of modafinil are limited in non-sleep-deprived middle-aged volunteers. Pharmacology Biochemistry and Behavior, 77, 547–555. doi:10.1016/j.pbb.2003.12.016
  • Randall, D. C., Shneerson, J. M., & File, S. E. (2005). Cognitive effects of modafinil in student volunteers may depend on IQ. Pharmacology Biochemistry and Behavior, 82, 133–139. doi:10.1016/j.pbb.2005.07.019
  • Riis, J., Simmons, J. P., & Goodwin, G. P. (2007). Preferences for enhancement pharmaceuticals: The reluctance to enhance fundamental traits. Journal of Consumer Research, 35, 495–508. Retrieved from http://www.jstor.org/stable/10.1086/588746
  • Robbins, T. W., & Sahakian, B. J. (1979). ‘Paradoxical’effects of psychomotor stimulant drugs in hyperactive children from the standpoint of behavioural pharmacology. Neuropharmacology, 18, 931–950. doi:10.1016/0028-3908(79)90157-6
  • Rogers, C. (1961). On becoming a person. Boston, MA: Houghton-Mifflin.
  • Runco, M., & Chand, I. (1995). Cognition and creativity. Educational Psychology Review, 7, 243–267. doi:10.1007/bf02213373
  • Runco, M. A., & Nemiro, J. (2003). Creativity in the moral domain: Integration and implications. Creativity Research Journal, 15, 91–105. doi:10.1207/s15326934crj1501_10
  • Sahakian, B. J., & Morein-Zamir, S. (2011). Neuroethical issues in cognitive enhancement. Journal of Psychopharmacology, 25, 197–204. doi:10.1177/0269881109106926
  • Sandberg, A., & Savulescu, J. (2011). The social and economic impact of cognitive enhancement. In R. T. Meulen, J. Savulescu, & G. Kahane (Eds.), Enhancing human capacities (pp. 92–113). Oxford, UK: Wiley-Blackwell.
  • Savulescu, J., Meulen, R. T., & Kahane, G. (2011). Enhancing human capacities. Oxford, UK: Wiley-Blackwell.
  • Seligman, M. E. P., & Csikszentmihalyi, M. (2000). Positive psychology: An introduction. American Psychologist, 55, 5–14. doi:10.1037/0003-066x.55.1.5
  • Sessa, B. (2008). Is it time to revisit the role of psychedelic drugs in enhancing human creativity? Journal of Psychopharmacology, 22, 821–827. doi:10.1177/0269881108091597
  • Snyder, C. R., & Lopez, S. J. (2009). Handbook of positive psychology (2nd ed.). New York, NY: Oxford University Press.
  • Spiller, H. A., Borys, D., Griffith, J. R. K., Klein-Schwartz, W., Aleguas, A., Anderson, D. A., & Sawyer, T. S. (2009). Toxicity from modafinil ingestion. Clinical Toxicology, 47, 153–156. doi:10.1080/15563650802175595
  • Stein, D. (2008). The philosophy of psychopharmacology: Happy pills, smart pills, pep pills. Cambridge, UK: Cambridge University Press.
  • Swanton, C. (2003). Creativity virtue ethics: A pluralistic view. Oxford, UK: Clarendon.
  • Taylor, C. (1991). The ethics of authenticity. Cambridge, MA: Harvard University Press.
  • Taylor, R. S. (2005). Kantian personal autonomy. Political Theory, 33, 602–628. Retrieved from http://ptx.sagepub.com/content/33/5/602.short
  • Teter, C. J., Falone, A. E., Cranford, J. A., Boyd, C. J., & McCabe, S. E. (2010). Nonmedical use of prescription stimulants and depressed mood among college students: Frequency and routes of administration. Journal of Substance Abuse Treatment, 38, 292–298. doi:10.1016/j.jsat.2010.01.005
  • Vaillant, G. E. (2012). Positive mental health: Is there a cross-cultural definition? World Psychiatry, 11, 93–99. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363378
  • Vastag, B. (2004). Poised to challenge need for sleep, ‘wakefulness enhancer’ rouses concerns. Journal of the American Medical Association, 291, 167–170. doi:10.1001/jama.291.2.167
  • Volkow, N., Fowler, J. S., Logan, J., Alexoff, D., Zhu, W., Telang, F., … Apelskog-Torres, K. (2009). Effects of modafinil on dopamine and dopamine transporters in the male human brain: Clinical implications. Journal of the American Medical Association, 301, 1148–1154. doi:10.1001/jama.2009.351

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.